Determinants of PRO-industry interactions in pharmaceutical R&D: the case of Mexico
AbstractInteractive learning, particularly between firms and public research organizations (PRO), nurtures the dynamics of systems of innovation. Limited interaction contributes to explain poor performance in R&D and ultimately, in innovation by developing countries. But why this is so? Based on evidence from the pharmaceutical industry in Mexico, this paper identifies some determinants of PRO-industry interaction for pharmaceutical R&D. Particular attention is granted to factors hindering such interactions; arguably the barriers differ throughout the diverse stages of the R&D process. The paper decomposes the Research and Development processes, thus it is possible to identify determinants to interactions in each of those instances. Drug development is further split in two stages: clinical research and drug manufacturing. The analysis indicates that macroeconomic and business environments, firms' strategies, ethical considerations, incentives and perceptions of PRO-industry interaction among the agents in the system, support/hinder interactivity in pharmaceutical R&D.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by United Nations University, Maastricht Economic and social Research and training centre on Innovation and Technology in its series UNU-MERIT Working Paper Series with number 053.
Date of creation: 2010
Date of revision:
Contact details of provider:
Web page: http://www.merit.unu.edu
Public research organizations; pharmaceutical industry; university-industry collaboration; pharmaceuticals; R&D; Mexico;
Other versions of this item:
- Santiago-Rodriguez, Fernando & Dutrenit, Gabriela, 2010. "Determinants of PRO-industry interactions in pharmaceutical R&D: the case of Mexico," MERIT Working Papers 053, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
- O31 - Economic Development, Technological Change, and Growth - - Technological Change; Research and Development; Intellectual Property Rights - - - Innovation and Invention: Processes and Incentives
- O54 - Economic Development, Technological Change, and Growth - - Economywide Country Studies - - - Latin America; Caribbean
- L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology
This paper has been announced in the following NEP Reports:
- NEP-ALL-2010-11-13 (All new papers)
- NEP-CSE-2010-11-13 (Economics of Strategic Management)
- NEP-INO-2010-11-13 (Innovation)
- NEP-IPR-2010-11-13 (Intellectual Property Rights)
- NEP-SBM-2010-11-13 (Small Business Management)
- NEP-TID-2010-11-13 (Technology & Industrial Dynamics)
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Santiago-Rodriguez, Fernando, 2008.
"Facing the Trial of Internationalizing Clinical Trials to Developing Countries: Some Evidence from Mexico,"
UNU-MERIT Working Paper Series
023, United Nations University, Maastricht Economic and social Research and training centre on Innovation and Technology.
- Santiago-Rodriguez, Fernando, 2008. "Facing the Trial of Internationalizing Clinical Trials to Developing Countries: Some Evidence from Mexico," MERIT Working Papers 023, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
- Welsh, Rick & Glenna, Leland & Lacy, William & Biscotti, Dina, 2008. "Close enough but not too far: Assessing the effects of university-industry research relationships and the rise of academic capitalism," Research Policy, Elsevier, vol. 37(10), pages 1854-1864, December.
- Fernando Santiago Rodr�guez, 2010. "Governing ethical clinical research in developing countries: exploring the case of Mexico," Science and Public Policy, Oxford University Press, vol. 37(8), pages 583-596, October.
- Chiesa, Vittorio, 1996. "Separating research from development: Evidence from the pharmaceutical industry," European Management Journal, Elsevier, vol. 14(6), pages 638-647, December.
- Paula E. Stephan, 1996. "The Economics of Science," Journal of Economic Literature, American Economic Association, vol. 34(3), pages 1199-1235, September.
- Gabriela Dutrénit & Claudia De Fuentes & Arturo Torres, 2010. "Channels of interaction between public research organisations and industry and their benefits: evidence from Mexico," Science and Public Policy, Oxford University Press, vol. 37(7), pages 513-526, August.
- Pavitt, Keith, 1998. "The social shaping of the national science base," Research Policy, Elsevier, vol. 27(8), pages 793-805, December.
- Wesley M. Cohen & Richard R. Nelson & John P. Walsh, 2002. "Links and Impacts: The Influence of Public Research on Industrial R&D," Management Science, INFORMS, vol. 48(1), pages 1-23, January.
- Henderson, Rebecca. & Cockburn, Iain., 1994. "Measuring competence? : exploring firm effects in pharmaceutical research," Working papers 3712-94., Massachusetts Institute of Technology (MIT), Sloan School of Management.
- Hobday, Michael & Rush, Howard & Bessant, John, 2004. "Approaching the innovation frontier in Korea: the transition phase to leadership," Research Policy, Elsevier, vol. 33(10), pages 1433-1457, December.
- Gassmann, Oliver & von Zedtwitz, Maximilian, 1999. "New concepts and trends in international R&D organization," Research Policy, Elsevier, vol. 28(2-3), pages 231-250, March.
- Freeman, Chris, 1995. "The 'National System of Innovation' in Historical Perspective," Cambridge Journal of Economics, Oxford University Press, vol. 19(1), pages 5-24, February.
- repec:ner:carlos:info:hdl:10016/6520 is not listed on IDEAS
- Santamara, Llus & Nieto, Mara Jess & Barge-Gil, Andrs, 2009. "Beyond formal R&D: Taking advantage of other sources of innovation in low- and medium-technology industries," Research Policy, Elsevier, vol. 38(3), pages 507-517, April.
- von Zedtwitz, Maximilian & Gassmann, Oliver, 2002. "Market versus technology drive in R&D internationalization: four different patterns of managing research and development," Research Policy, Elsevier, vol. 31(4), pages 569-588, May.
- Mazzoleni, Roberto & Nelson, Richard R., 2007. "Public research institutions and economic catch-up," Research Policy, Elsevier, vol. 36(10), pages 1512-1528, December.
- repec:ner:maastr:urn:nbn:nl:ui:27-25266 is not listed on IDEAS
- Cohen, Wesley M & Levinthal, Daniel A, 1989. "Innovation and Learning: The Two Faces of R&D," Economic Journal, Royal Economic Society, vol. 99(397), pages 569-96, September.
- Monjon, Stephanie & Waelbroeck, Patrick, 2003. "Assessing spillovers from universities to firms: evidence from French firm-level data," International Journal of Industrial Organization, Elsevier, vol. 21(9), pages 1255-1270, November.
- Laursen, Keld & Salter, Ammon, 2004. "Searching high and low: what types of firms use universities as a source of innovation?," Research Policy, Elsevier, vol. 33(8), pages 1201-1215, October.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Ad Notten).
If references are entirely missing, you can add them using this form.